![]() AXIM Biotechnologies AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. | ![]() Kaya Holdings Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies. | ![]() Zynerba Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. | |
Founding Date | Founding Date 2010 | Founding Date 1993 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ San Diego, US | Locations Fort Lauderdale, US HQ Kallithea, GR Tzur Yitzhak, IL | Locations Devon, US HQ |
Employees | Employees 6 | Employees 620% increase | Employees 2511% decrease |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) 1 m | Valuation ($) 70.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $39.5k (FY, 2023) | Revenue (est.) $7.1k (FY, 2024) | Revenue (est.) N/A |
Net income | Net income ($8.1m) (FY, 2023) | Net income ($2.2m) (FY, 2024) | Net income ($35m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 115k | Total funding raised N/A | Total funding raised $ 16.5m |

Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies.
View company
Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions.
View company